Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Commercial
Patent
Patent
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Patent
RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences Other OTC:RSPI
Globenewswire News
-
January 8, 2021
Patent
Aquestive Therapeutics Provides Business Update Nasdaq:AQST
Patent
Canopy Growth Files Patent Infringement Lawsuit Against GW Pharmaceuticals – FirstWord Pharma
Patent
Mountain Valley MD Files for Acceleration of Patent Examination for Solubilized Ivermectin – FirstWord Pharma
Patent
COVID-19 severity affected by proportion of antibodies targeting crucial viral protein, study finds – FirstWord Pharma
Patent
Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin...
Biospace News
-
December 24, 2020
0
Patent
ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell...
-
December 23, 2020
0
Patent
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility Nasdaq:TNXP
Globenewswire News
-
December 23, 2020
0
Patent
BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team
Biospace News
-
December 23, 2020
0
Patent
Monopar Announces Issuance of U.S. Patent Covering Compositions of Matter for...
Globenewswire News
-
December 22, 2020
0
1
2
3
...
20
Page 1 of 20
- Advertisement -
MOST POPULAR
Tesamorelin Study Results on NAFLD Published in Lancet HIV
October 11, 2019
Karyopharm’s Xpovio Hits the Mark in Phase III Multiple Myeloma Trial
March 3, 2020
Zosano Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate...
November 14, 2019
FDA Gives ADMA’s Asceniv for Immune Deficiency the Thumbs-Up
April 2, 2019
Load more
HOT NEWS
Acquisitions
Danaher to Acquire the Biopharma Business of General Electric Life Sciences...
Commercial
COVID-19 News: Vaccine Protection Likely to Last for Years, Be Effective...
Others
Scottish Medicines Consortium December 2019 decisions news release
Deals
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel...
